Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07372014Phase 4Active, not recruiting
A Phase 4 trial of nepafenac in epiphora, Lacrimal punctal stenosis, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Started Jan 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07372014.